logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-38. All clients in treatment (treatment prevalence) for primary use of amphetamines, ecstasy and other stimulants (other than cocaine) in countries reporting in 2006: demographics and patterns of drug use

CountryMean ageGender ratioMean age at first drug use% Daily Users% IV use
Bulgaria(1)22.53.017.823.07.7
Czech Republic(2)25.42.118.950.082.6
France(3)28.72.520.313.33.3
Italy(1)26.92.319.129.91.8
Latvia(1)27.02.922.134.778.5
Hungary(1)25.92.320.48.3
Malta(3)24.12.018.50.00
Netherlands(2)26.38.219.341.72.2

Notes:

 Only countries supplying data are reported 

 (1) Data from outpatient treatment centres 

 (2) Data from outpatient and inpatient treatment centres and low threshold agencies 

 (3) Data from outpatient and inpatient treatment centres and prison 

 See also Tables TDI-39 and TDI-40 on treatment prevalence.     

 See also Tables Table TDI-10, TDI-102, TDI-21, TDI-11, TDI-106, TDI-18, TDI-17 part (iii) and TDI-17 part (vii).     

Sources:

 2007 Pilot Data collection on Treatment Prevalence. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008